6-AN pre-treatment induced a significant reduction in NADPH levels and an increased production of ROS in renal cancer cells, suggesting that G6PDH, and consequently the PPP, have a fundamental role in maintaining redox homeostasis in RCC. The gene discussed is H6PD; the disease is renal cell carcinoma.